Zusammenfassung
Das Spektrum der Pharmakotherapie in der psychiatrischen Notfalltherapie wird ausführlich beschrieben. Delirante Syndrome nehmen einen breiteren Raum ein. Intoxikationen sind den spezifischen Kapiteln zugeteilt.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Anderson EL, Nordstrom K, Wilson MP et al (2017) American association for emergency psychiatry task force on medical clearance of adults part I: introduction, review and evidence-based guidelines. West J Emerg Med 18(2):235–242
DGPPN (Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde) (2019a) S2k-Leitlinie Notfallpsychiatrie. AWMF-Register-Nr. 038-023. https://www.awmf.org/uploads/tx_szleitlinien/038-023l_S2k_Notfallpsychiatrie_2019-05_1.pdf. Zugegriffen: 13. Apr. 2019
DGPPN (Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde e. V.) , Leitliniengruppe: S3-Leitlinie Schizophrenie (Hrsg) (2019b) S3-Leitlinie Schizophrenie. AWMF-Register Nr. 038-009. Langfassung. https://www.awmf.org/leitlinien/detail/ll/038-009.html. Zugegriffen: 15. März 2019
Garriga M, Pacchiarotti I, Kasper S et al (2016) Assessment and management of agitation in psychiatry: expert consensus. World J Biol Psychiatry 17(2):86–128
Jayakody K, Gibson RC, Kumar A, Gunadasa S (2012) Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses. Cochrane Database Syst Rev 18(4):CD525
Knorr R, Schöllkopf J, Haen E (2018) Das maligne neuroleptische Syndrom. Nervenarzt 89(3):300–310
Martínez-Raga J, Amore M, Di Sciascio G et al (2018) 1st international experts’ meeting on agitation: conclusions regarding the current and ideal management paradigm of agitation. Front Psychiatry 9:54
Nagel M, Freisberg S, Junghanns K et al (2015) Das maligne neuroleptische Syndrom (MNS) – Eine systematische Übersicht. Fortschr Neurol Psychiatr 83:373–380
Nishikimi M, Numaguchi A, Takahashi K et al (2018) Effect of administration of ramelteon, a melatonin receptor agonist, on the duration of stay in the ICU: a single-center randomized placebo-controlled trial. Crit Care Med 46(7):1099–1105
Ostinelli EG, Brooke-Powney MJ, Li X, Adams CE (2017) Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev 7:CD9377
Pelzer AC, van der Heijden FM, den Boer E (2018) Systematic review of catatonia treatment. Neuropsychiatr Dis Treat 14:317–326
Pepa PA, Lee KC, Huynh HE, Wilson MP (2017) Safety of risperidone for acute agitation and alcohol intoxication in emergency department patients. J Emerg Med 53(4):530–535
Schmidt A, Fischer P, Wally B, Scharfetter J (2017) Influence of intravenous administration of the antipsychotic drug benperidol on the QT interval. Neuropsychiatr 31(4):172–175
Schönfeldt-Lecuona C, Kuhlwilm L, Cronemeyer M et al (2020) Treatment of the neuroleptic malignant syndrome in international therapy guidelines: a comparative analysis. Pharmacopsychiatry 53(2):51–59
Tebartz van Elst L, Bechter K, Prüss H et al (2019) Autoantikörper-assoziierte schizophreniforme Psychosen: Pathophysiologie, Diagnostik und Therapie. Nervenarzt 90(7):745–761
Utzerath G, Reske D, Gouzoulis-Mayfrank E (2015) Parenteral applizierte Antipsychotika bei Agitation und Aggression. Fortschr Neurol Psychiatr 83:665–675
Wahidi N, Johnson KM, Brenzel A, de Leon J (2016) Two sudden and unexpected deaths of patients with schizophrenia associated with intramuscular injections of antipsychotics and practice guidelines to limit the use of high doses of intramuscular antipsychotics. Case Rep Psychiatry 2016:9406813
Wilson MP, Pepper D, Currier GW et al (2012) The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry project Beta Psychopharmacology Workgroup. West J Emerg Med 13(1):26–34
Zoremba N, Coburn M (2019) Delir im Krankenhaus. Dtsch Arztebl 116:101–106
Zun LS (2018a) Evidence-based review of pharmacotherapy for acute agitation. Part 1: Onset of efficacy. J Emerg Med 54(3):364–374
Zun LS (2018b) Evidence-based review of pharmacotherapy for acute agitation. Part 2: Safety. J Emerg Med 54(4):522–532
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Müller, M.J., Benkert, O. (2021). Pharmakotherapie psychiatrischer Notfallsituationen. In: Benkert, O., Hippius, H. (eds) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-61753-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-662-61753-3_12
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-61752-6
Online ISBN: 978-3-662-61753-3
eBook Packages: Medicine (German Language)